Reports
The expanding cases of lateral epicondylitis among a considerable chunk of the global populace coupled with the increasing focus on upgrading the healthcare infrastructure may bring considerable growth prospects for the lateral epicondylitis (tennis elbow) market during the forecast period of 2021-2031. In addition, the technological developments across the lateral epicondylitis (tennis elbow) market over the years may also bring profitable growth avenues.
Lateral epicondylitis, also known as tennis elbow, is a health condition where swelling of the tendons is experienced. It bends the wrist backwards from the palm. It occurs when one’s elbows are under extensive strain often by the repetitive motion of the arm and the wrist. This condition is frequent among sports players and athletes. The rising inclination of many individuals toward sports activities has resulted in high cases of lateral epicondylitis (tennis elbow), ultimately contributing to the growth of the global market.
The report from Transparency Market Research highlights various factors that influence the growth of the lateral epicondylitis (tennis elbow) market. Insights into the competitive dimensions, regional aspects, and key trends have also been included in the report. In addition, the report also mentions the impact of the COVID-19 pandemic on the lateral epicondylitis (tennis elbow) market. Threat projections and potential growth hindrances are also covered extensively in this report.
The lateral epicondylitis (tennis elbow) market is highly competitive. The players are involved in product launches, innovative marketing campaigns, and other activities related to awareness generation among the prospective consumers. In addition, research and development activities also form an important part of the lateral epicondylitis (tennis elbow) market growth trajectory. The players indulge in these activities for discovering novel insights into the treatment of lateral epicondylitis (tennis elbow), ultimately contributing to the growth of the lateral epicondylitis (tennis elbow) market.
Strategic collaborations are also important for the overall growth of the lateral epicondylitis (tennis elbow) market. The players indulge in mergers, acquisitions, joint ventures, and partnerships. These activities help in expanding the influence of the players across the lateral epicondylitis (tennis elbow) market, eventually increasing the growth rate.
Some well-established players in the lateral epicondylitis (tennis elbow) market are 3M, Teikoku Pharma USA, Inc., Aksigen, Zimmer Bionet, and DJO Global, Inc.
The increasing geriatric population base is one of the crucial factors that positively impacts the growth trajectory of the lateral epicondylitis (tennis elbow) market as this condition is common among the elderly people. The rising baby-boomer population and the growing awareness about the treatment related to lateral epicondylitis (tennis elbow) may serve as prime growth factors.
Non-surgical treatments are preferred by many individuals for treating lateral epicondylitis. These therapies include extracorporeal shock wave therapy, medications, physical therapies, and braces. The use of anti-inflammatory drugs such as cortisone, ibuprofen, and aspirin is also proving to be beneficial for the growth of the lateral epicondylitis (tennis elbow) market. The use of extracorporeal shock wave therapy to encourage natural healing process in the body may bring considerable growth opportunities for the lateral epicondylitis (tennis elbow) market.
The government bodies of numerous countries are concentrating extensively on upgrading their healthcare infrastructure. In addition, favorable reimbursement policies are being introduced by various countries. The policies include more than 80% knee braces reimbursement. These factors are expected to have an indirect positive impact on the lateral epicondylitis (tennis elbow) market.
North America is projected to emerge as a crucial growth-contributing region for the lateral epicondylitis (tennis elbow) market. The growing awareness about the treatment of lateral epicondylitis (tennis elbow) among numerous individuals and the presence of a well-established healthcare infrastructure may serve as growth accelerators for the lateral epicondylitis (tennis elbow) market in North America.
N/A